196 related articles for article (PubMed ID: 28960464)
1. Phosphodiesterase III inhibitor attenuates rat sinusoidal obstruction syndrome through inhibition of platelet aggregation in Disse's space.
Miyata T; Tajima H; Hirata M; Nakanuma SI; Makino I; Hayashi H; Oyama K; Miyashita T; Takamura H; Ninomiya I; Fushida S; Iseki S; Harada SI; Wakayama T; Ohta T
J Gastroenterol Hepatol; 2018 Apr; 33(4):950-957. PubMed ID: 28960464
[TBL] [Abstract][Full Text] [Related]
2. Extravasated platelet aggregation in the livers of rats with drug‑induced hepatic sinusoidal obstruction syndrome.
Hirata M; Tajima H; Miyashita T; Miyata T; Nakanuma S; Makino I; Hayashi H; Oyama K; Takamura H; Ninomiya I; Fushida S; Nakata H; Iseki S; Harada S; Wakayama T; Ohta T
Mol Med Rep; 2017 May; 15(5):3147-3152. PubMed ID: 28358421
[TBL] [Abstract][Full Text] [Related]
3. Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9.
Nakamura K; Hatano E; Narita M; Miyagawa-Hayashino A; Koyama Y; Nagata H; Iwaisako K; Taura K; Uemoto S
J Hepatol; 2012 Nov; 57(5):1037-43. PubMed ID: 22796153
[TBL] [Abstract][Full Text] [Related]
4. Soluble Thrombomodulin Attenuates Endothelial Cell Damage in Hepatic Sinusoidal Obstruction Syndrome.
Takada S; Miyashita T; Yamamoto Y; Kanou S; Munesue S; Ohbatake Y; Nakanuma S; Okamoto K; Sakai S; Kinoshita J; Makino I; Nakamura K; Tajima H; Takamura H; Ninomiya I; Fushida S; Ohta T
In Vivo; 2018; 32(6):1409-1417. PubMed ID: 30348695
[TBL] [Abstract][Full Text] [Related]
5. Regorafenib suppresses sinusoidal obstruction syndrome in rats.
Okuno M; Hatano E; Nakamura K; Miyagawa-Hayashino A; Kasai Y; Nishio T; Seo S; Taura K; Uemoto S
J Surg Res; 2015 Feb; 193(2):693-703. PubMed ID: 25266603
[TBL] [Abstract][Full Text] [Related]
6. Quercetin and baicalein suppress monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats.
Zhang J; Sheng Y; Shi L; Zheng Z; Chen M; Lu B; Ji L
Eur J Pharmacol; 2017 Jan; 795():160-168. PubMed ID: 27979702
[TBL] [Abstract][Full Text] [Related]
7. Cilostazol improves the prognosis after hepatectomy in rats with sinusoidal obstruction syndrome.
Sugita H; Nakanuma S; Munesue S; Ishikawa T; Tokoro T; Takei R; Okazaki M; Kato K; Takada S; Makino I; Ozaki N; Yamamoto Y; Yagi S
J Gastroenterol Hepatol; 2024 Feb; ():. PubMed ID: 38348885
[TBL] [Abstract][Full Text] [Related]
8. Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1.
Nakamura K; Hatano E; Miyagawa-Hayashino A; Okuno M; Koyama Y; Narita M; Seo S; Taura K; Uemoto S
Liver Int; 2014 Nov; 34(10):1473-87. PubMed ID: 24498917
[TBL] [Abstract][Full Text] [Related]
9. Thrombopoietin accumulation in hepatocytes induces a decrease in its serum levels in a sinusoidal obstruction syndrome model.
Yamazaki H; Tajima H; Yamamoto Y; Munesue S; Okazaki M; Ohbatake Y; Nakanuma S; Makino I; Miyashita T; Takamura H; Ohta T
Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35475446
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory Effects of Beraprost Sodium in Murine Hepatic Sinusoidal Obstruction Syndrome.
Nakura M; Miyashita T; Yamamoto Y; Takada S; Kanou S; Tajima H; Takamura H; Ohta T
Anticancer Res; 2020 Sep; 40(9):5171-5180. PubMed ID: 32878805
[TBL] [Abstract][Full Text] [Related]
11. Melatonin attenuates monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats via activation of Sirtuin-3.
Ren X; Xu K; Xu J; Mei Q
J Biochem Mol Toxicol; 2023 Sep; 37(9):e23422. PubMed ID: 37350538
[TBL] [Abstract][Full Text] [Related]
12. Liquiritigenin and liquiritin alleviated monocrotaline-induced hepatic sinusoidal obstruction syndrome via inhibiting HSP60-induced inflammatory injury.
Huang Z; Zhao Q; Chen M; Zhang J; Ji L
Toxicology; 2019 Dec; 428():152307. PubMed ID: 31589899
[TBL] [Abstract][Full Text] [Related]
13. Chlorogenic acid suppresses monocrotaline-induced sinusoidal obstruction syndrome: The potential contribution of NFκB, Egr1, Nrf2, MAPKs and PI3K signals.
Zheng Z; Shi L; Sheng Y; Zhang J; Lu B; Ji L
Environ Toxicol Pharmacol; 2016 Sep; 46():80-89. PubMed ID: 27438897
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Effect of Recombinant Human Soluble Thrombomodulin for Hepatic Sinusoidal Obstruction Syndrome Model Mice.
Kanou S; Miyashita T; Yamamoto Y; Takada S; Nakura M; Okazaki M; Ohbatake Y; Nakanuma S; Makino I; Tajima H; Takamura H; Fushida S; Ohta T
In Vivo; 2020; 34(3):1037-1045. PubMed ID: 32354890
[TBL] [Abstract][Full Text] [Related]
15. A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction.
Narita M; Hatano E; Ikai I; Miyagawa-Hayashino A; Yanagida A; Nagata H; Asechi H; Taura K; Uemoto S
Ann Surg; 2009 May; 249(5):806-13. PubMed ID: 19387321
[TBL] [Abstract][Full Text] [Related]
16. The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats.
Ezzat T; van den Broek MA; Davies N; Dejong CH; Bast A; Malagó M; Dhar DK; Olde Damink SW
J Surg Oncol; 2012 Jul; 106(1):72-8. PubMed ID: 22287334
[TBL] [Abstract][Full Text] [Related]
17. The involvement of Nrf2 antioxidant signalling pathway in the protection of monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats by (+)-catechin hydrate.
Jing X; Zhang J; Huang Z; Sheng Y; Ji L
Free Radic Res; 2018 Apr; 52(4):402-414. PubMed ID: 29458270
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epicatechin attenuates hepatic sinusoidal obstruction syndrome by inhibiting liver oxidative and inflammatory injury.
Huang Z; Jing X; Sheng Y; Zhang J; Hao Z; Wang Z; Ji L
Redox Biol; 2019 Apr; 22():101117. PubMed ID: 30822691
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model.
Robinson SM; Mann J; Vasilaki A; Mathers J; Burt AD; Oakley F; White SA; Mann DA
J Hepatol; 2013 Aug; 59(2):318-26. PubMed ID: 23624001
[TBL] [Abstract][Full Text] [Related]
20. Platelets prevent the development of monocrotaline-induced liver injury in mice.
Otaka F; Ito Y; Goto T; Eshima K; Amano H; Koizumi W; Majima M
Toxicol Lett; 2020 Dec; 335():71-81. PubMed ID: 33122006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
